Dr. Crew on Treatment in Favorable-Risk HER2+ Breast CancerByKatherine Crew, MD, MSFebruary 14th 2020Katherine Crew, MD, MS, discusses treatment for patients with favorable-risk early-stage HER2-positive breast cancer.
Dr. Crew on New Research in Advanced HER2+ Breast CancerByKatherine Crew, MD, MSFebruary 4th 2020Katherine Crew, MD, MS, discusses new research in the advanced HER2-positive breast cancer landscape.